美盛文化(002699.SZ):控股股東協議轉讓5%股份予九州國泰
格隆匯12月10日丨美盛文化(002699.SZ)公佈,公司近日接到控股股東美盛控股的通知,為歸還股票質押融資貸款,美盛控股於2020年12月9日與九州國泰簽訂了《股份轉讓協議》。美盛控股擬通過協議轉讓方式向九州國泰轉讓其持有公司4547.8637萬股無限售流通股,佔公司股份總數的5%,雙方一致同意此次股權轉讓價格為7.4元/股,對應的標的股權轉讓總價款約為3.3654億元。
此次股權協議轉讓後,美盛控股持有公司股份約2.5605億股,佔公司總股本的28.15%;九州國泰持有公司股份4547.8637萬股,佔公司總股本的5%。此次股權協議轉讓不會導致公司控制權發生變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.